Engineered Fluorescent Variants of Lactadherin C2 Domain for Phosphatidylserine Detection in Flow Cytometry. [PDF]
Koltsova E+4 more
europepmc +1 more source
Pharmacokinetics modulation in solid tumors through thrombin-embedded nanomedicine. [PDF]
Lin S+12 more
europepmc +1 more source
Heparin Tolerance Determinating Factors Evaluated by the Heparin Thrombin Clotting Time [PDF]
Per Kragh Andersen, H. C. Godal
openalex +1 more source
Discovering new hub genes of dilated cardiomyopathy
Abstract Aims Dilated cardiomyopathy (DCM) has a poor prognosis and exhibits a complex and diverse aetiology and genetic profile. The genes responsible for the pathogenesis of DCM have not been fully identified. The present study aimed to explore new hub genes of DCM by mining the human DCM databases and further by experimental validation.
Jun‐Yan Zhu+9 more
wiley +1 more source
Consistent Killers: Conservation of Thrombin-Like Action on Fibrinogen by Bushmaster (<i>Lachesis</i> Species) Venoms Underpins Broad Antivenom Cross-Reactivities. [PDF]
Jones L, Fry BG.
europepmc +1 more source
Photoaffinity labeling of a single receptor for alpha-thrombin on mouse embryo cells.
Darrel H. Carney+5 more
openalex +1 more source
Percutaneous mechanical circulatory support for acute right heart failure: A practical approach
This is an overview of percutaneous mechanical circulatory support options for acute right heart failure, illustrating key clinical scenarios, device types, and principles of tailored device selection based on haemodynamics and underlying pathology. Abstract Acute right heart failure (RHF) represents a critical entity with significant morbidity and ...
Mario Gramegna+18 more
wiley +1 more source
Cost-effective screening strategy to prevent venous thromboembolism in combined oral contraceptive users. [PDF]
Douxfils J.
europepmc +1 more source
Current and novel biomarkers in cardiogenic shock
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko+5 more
wiley +1 more source